Imugene Ltd
ASX:IMU
Imugene Ltd
ASX:IMU
Price:
0.085 AUD
1.19%
Market Closed
Updated:
May 2, 2024
Imugene Ltd
Cash from Operating Activities
|
Imugene Ltd
Cash from Operating Activities Peer Comparison
Comparables:
IMM
MSB
CSL
CUV
TLX
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Imugene Ltd
ASX:IMU
|
Cash from Operating Activities
-AU$31.5m
|
CAGR 3-Years
-43%
|
CAGR 5-Years
-38%
|
CAGR 10-Years
-43%
|
|
|
Immutep Ltd
ASX:IMM
|
Cash from Operating Activities
-AU$35.4m
|
CAGR 3-Years
-34%
|
CAGR 5-Years
-29%
|
CAGR 10-Years
-10%
|
|
|
Mesoblast Ltd
ASX:MSB
|
Cash from Operating Activities
-$59.1m
|
CAGR 3-Years
16%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
|
CSL Ltd
ASX:CSL
|
Cash from Operating Activities
$2.7B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
11%
|
CAGR 10-Years
9%
|
|
|
Clinuvel Pharmaceuticals Ltd
ASX:CUV
|
Cash from Operating Activities
AU$42.3m
|
CAGR 3-Years
31%
|
CAGR 5-Years
23%
|
CAGR 10-Years
N/A
|
|
|
Telix Pharmaceuticals Ltd
ASX:TLX
|
Cash from Operating Activities
AU$23.9m
|
CAGR 3-Years
130%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Imugene Ltd's Cash from Operating Activities?
Cash from Operating Activities
-31.5m
AUD
-31.5m
AUD
Based on the financial report for Dec 31, 2023, Imugene Ltd's Cash from Operating Activities amounts to -31.5m AUD.
What is Imugene Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
-43%
-43%
Over the last year, the Cash from Operating Activities growth was 24%. The average annual Cash from Operating Activities growth rates for Imugene Ltd have been -43% over the past three years , -38% over the past five years , and -43% over the past ten years .
You don't have any saved screeners yet
